Shangrong Medical (002551.SZ) released its first three quarters performance, with a net loss attributable to shareholders of RMB 32.7904 million.

Zhitong Finance APP News, Shangrong Medical (002551.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 836 million yuan, a year-on-year increase of 10.90%; net loss attributable to shareholders of the listed company was 32.7904 million yuan; net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 42.2146 million yuan; basic earnings per share was -0.0388 yuan.